Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Nanotechnology
• Cancer Biology

Background:

• Polyamines are crucial for cell growth and proliferation.
• Polyamines are implicated in various cancers.
• PG11047 is a polyamine analog that inhibits cancer cell growth.

Purpose of the Study:

• To synthesize and characterize novel polyamine analogs (HPGs) based on PG11047.
• To investigate the structure-activity relationship (SAR) of HPGs with varying alkyl chain lengths.
• To evaluate the anticancer and spermine oxidase (SMOX) inhibitory activities of HPGs.

Main Methods:

• Synthesis of HPG analogs with different alkyl chain lengths.
• Characterization of HPG self-assembly into nanoparticles.
• In vitro assessment of anticancer activity against HCT116 and A549 cell lines.
• Evaluation of SMOX inhibition activity.

Main Results:

• HPG analogs self-assembled into spherical nanoparticles, with size correlating to alkyl chain length.
• HPGs with longer alkyl chains exhibited significantly enhanced in vitro anticancer activity against colon and lung cancer cells compared to PG11047.
• HPG analogs demonstrated potent inhibition of spermine oxidase (SMOX), with the best analog showing nine-fold greater activity than a reference inhibitor.

Conclusions:

• Alkyl chain length is a critical determinant of HPG anticancer and SMOX inhibitory activity.
• HPG analogs represent promising drug candidates for cancer therapy due to their enhanced efficacy and novel mechanism of action.
• The self-assembly into nanoparticles may contribute to the improved therapeutic potential of HPG analogs.